Showing 1 - 11 results of 11 for search 'Masayo Sato', query time: 0.04s Refine Results
  1. 1
    Treatment for Osteoporosis among Women in Japan: Associations with Patient Characteristics and Patient-Reported Outcomes in the 2008–2011 Japan National Health and Wellness Surveys

    Treatment for Osteoporosis among Women in Japan: Associations with Patient Characteristics and Patient-Reported Outcomes in the 2008–2011 Japan National Health and Wellness Surveys... by Masayo Sato, Jeffrey Vietri, Jennifer A. Flynn, Saeko Fujiwara

    Published 2014-01-01
    Get full text
    Article
  2. 2
    Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes

    Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes by Sheila Weiss Smith, Masayo Sato, Steven D. Gore, Maria R. Baer, Xuehua Ke, Diane McNally, Amy Davidoff

    Published 2012-01-01
    Get full text
    Article
  3. 3
    Adherence and Persistence with Once-Daily Teriparatide in Japan: A Retrospective, Prescription Database, Cohort Study

    Adherence and Persistence with Once-Daily Teriparatide in Japan: A Retrospective, Prescription Database, Cohort Study by Ikuko Tanaka, Masayo Sato, Tomoko Sugihara, Douglas E. Faries, Shuko Nojiri, Peita Graham-Clarke, Jennifer A. Flynn, Russel T. Burge

    Published 2013-01-01
    Get full text
    Article
  4. 4
    Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome

    Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome by Taro Akihisa, Masayo Sato, Yoshie Wakayama, Sekiko Taneda, Shigeru Horita, Orie Hirose, Shiho Makabe, Hiroshi Kataoka, Takayasu Mori, Eisei Sohara, Shinichi Uchida, Kosaku Nitta, Toshio Mochizuki

    Published 2019-11-01
    Get full text
    Article
  5. 5
    Germline Mutations for Kidney Volume in ADPKD

    Germline Mutations for Kidney Volume in ADPKD by Hiroshi Kataoka, Rie Yoshida, Naomi Iwasa, Masayo Sato, Shun Manabe, Keiko Kawachi, Shiho Makabe, Taro Akihisa, Yusuke Ushio, Atsuko Teraoka, Ken Tsuchiya, Kosaku Nitta, Toshio Mochizuki

    Published 2022-03-01
    Get full text
    Article
  6. 6
    Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease

    Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease by Hiroshi Kataoka, Hiroyuki Akagawa, Yusuke Ushio, Masayo Sato, Shun Manabe, Shiho Makabe, Keiko Kawachi, Taro Akihisa, Naomi Iwasa, Rie Yoshida, Ken Tsuchiya, Kosaku Nitta, Toshio Mochizuki

    Published 2022-09-01
    Get full text
    Article
  7. 7
    Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease

    Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease by Hiroshi Kataoka, Hiroyuki Akagawa, Rie Yoshida, Naomi Iwasa, Yusuke Ushio, Taro Akihisa, Masayo Sato, Shun Manabe, Shiho Makabe, Keiko Kawachi, Junichi Hoshino, Ken Tsuchiya, Kosaku Nitta, Toshio Mochizuki

    Published 2022-10-01
    Get full text
    Article
  8. 8
    High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study

    High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study by Masayo Sato, Hiroshi Kataoka, Yusuke Ushio, Shun Manabe, Saki Watanabe, Taro Akihisa, Shiho Makabe, Rie Yoshida, Naomi Iwasa, Michihiro Mitobe, Norio Hanafusa, Ken Tsuchiya, Kosaku Nitta, Toshio Mochizuki

    Published 2020-03-01
    Get full text
    Article
  9. 9
    Visceral to subcutaneous fat ratio as an indicator of a ≥30% eGFR decline in chronic kidney disease.

    Visceral to subcutaneous fat ratio as an indicator of a ≥30% eGFR decline in chronic kidney disease. by Hiroshi Kataoka, Toshio Mochizuki, Kazuhiro Iwadoh, Yusuke Ushio, Keiko Kawachi, Saki Watanabe, Kentaro Watanabe, Taro Akihisa, Shiho Makabe, Shun Manabe, Masayo Sato, Naomi Iwasa, Rie Yoshida, Yukako Sawara, Norio Hanafusa, Ken Tsuchiya, Kosaku Nitta

    Published 2020-01-01
    Get full text
    Article
  10. 10
    Machine learning for morbid glomerular hypertrophy

    Machine learning for morbid glomerular hypertrophy by Yusuke Ushio, Hiroshi Kataoka, Kazuhiro Iwadoh, Mamiko Ohara, Tomo Suzuki, Maiko Hirata, Shun Manabe, Keiko Kawachi, Taro Akihisa, Shiho Makabe, Masayo Sato, Naomi Iwasa, Rie Yoshida, Junichi Hoshino, Toshio Mochizuki, Ken Tsuchiya, Kosaku Nitta

    Published 2022-11-01
    Get full text
    Article
  11. 11
    Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study.

    Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study. by Hiroshi Kataoka, Mamiko Ohara, Tomo Suzuki, Takahiro Inoue, Takafumi Akanuma, Keiko Kawachi, Shun Manabe, Yusuke Ushio, Kentaro Kawasoe, Taro Akihisa, Masayo Sato, Naomi Iwasa, Yukako Sawara, Kazuho Honda, Toshio Mochizuki, Ken Tsuchiya, Kosaku Nitta

    Published 2020-01-01
    Get full text
    Article

Search Tools: